1. Market Research
  2. > Pharmaceutical Market Trends
Europe Pharmaceutical Logistics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

Europe Pharmaceutical Logistics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

  • October 2021
  • 352 pages
  • ID: 6177371
  • Format: PDF
  • Mordor Intelligence LLP


Table of Contents

Search Inside

The European Pharmaceutical Logistics Market is expected to grow at a CAGR of more than 4% during the forecast period. The market growth can be seen as a result of Covid-19, with an increase in pharmaceutical product imports (USD 361 billion) and exports (USD 524 billion) in the year 2020.

Logistics is an essential segment of supply chain management. It allows the pharmaceutical sector to establish consistency as well as efficiency through the international supply chain market. The pharmaceutical sector opts for logistics for complete management of acquiring, storing, and moving the resources to the end-users as per their needs. European Association for Logistics and Transportation in Healthcare (EALTH) is one association that aims to achieve the same in Europe.

The demand for pharmaceutical logistics in Europe is mainly driven by the increase in demand for drugs and vaccines, fueled by the pandemic and increasing investments by leading pharmaceutical firms. The rising importance of fast-track assistance in the healthcare sector is a key driver for pharmaceutical logistics. Companies in the industry are focusing on decreasing the distribution cost by creating a single source distribution channel, thus driving the growth of pharmaceutical logistics. Several companies are entering M&As to expand their geographical presence and proprietary knowledge. They are also focusing on reducing the overall packaging costs of their products.

Key Market Trends

Growing European Pharmaceutical Industry

Europe is the second-largest biopharmaceuticals market in the world. Increasing population and chronic diseases are propelling market growth. The adoption and accessibility, availability of biopharmaceuticals for the treatment and diagnosis of diseases, and awareness related to medicine raised the European market. Western Europe contains more than 33% of manufacturing facilities worldwide. Biopharma products have high efficiency with safety than other products.

The development of complex biological-based medicines and shipment of hormone treatments, vaccines, and complex proteins that require cold chain refinements result in the need for temperature-controlled transportation and warehousing. In addition, an increase in the need for effective cold chain logistics services to maintain the quality of goods fuels the growth of the market.

In June 2020, the European Commission (EC) launched the public input its proposed pharmaceutical strategy for Europe to ensure Europe’s supply of safe and affordable medicines to meet patients’ needs and support the European pharmaceutical industry to remain an innovator and world leader.

The strategy aims to create what the EC terms a “future-proof” system and is centered on several key themes, strategic autonomy and manufacturing of medicines, access to affordable medicines, innovation, and environmental sustainability, and health challenges.

Germany Leads the Export of Pharmaceutical Products in Europe

Germany is the largest pharmaceutical market in Europe and the fourth-largest in the world, according to Germany Trade and Invest (GTAI). The country is regarded as one of the world’s leading places for pharmaceutical manufacture, and its highly skilled workforce enables pharmaceutical companies to work on more complicated and demanding goods like biosimilars while maintaining high production quality.

Germany’s population of over 84 million people makes it an ideal location for clinical trials, especially those with difficult participant recruitment. With 68 commercial Phase I clinical studies started in 2018, Germany ranked fourth after the United Kingdom, China, and the United States. Germany is the ideal location for the development and manufacture of high-quality, research-intensive products. In 2019, Germany ranked sixth in the world with 499 clinical trials funded by research-based pharmaceutical corporations. The country leads Europe in pharmaceutical innovation based on the number of patent applications. The pharmaceutical business in Germany registered 584 patents with the European Patent Office in 2018.

The total German pharmaceutical market clinic and pharmacy section had grown by over 7% to EUR 49.5 billion in 2020. Vaccines and diagnostics are also included in this section. According to an industry report, the amount by counting units, such as tablets, sachets, and injections, decreased slightly (-0.6 %) to 97.5 billion counting units. Each of the clinic and pharmacy segments saw a 6 to 7% gain in value. The amount consumed in clinics, on the other hand, decreased by 10%, while sales in the pharmacy industry remained unchanged, according to the report. These developments are linked to the COVID-19 pandemic, as hospital operations have been postponed to make room for COVID-19 patients. Certain medications were also less needed as a result of this. All of the drug classes with the most volume in the clinic market saw reductions.

Competitive Landscape

The European Pharmaceutical Logistics Market is highly competitive and is fragmented. The European region has the presence of both regional and international players in the market. The competition in the pharma logistics sector is escalating, and service providers are seeking an edge by continuously adapting to the changing marketplace. With Increasing pharmaceutical sales worldwide, the demand for pharmaceutical logistics service providers has also increased with the increasing sales. The opportunity for logistics service providers is likely to grow rapidly in the coming years. Some of the existing major players in the market include – DHL Supply Chain, FedEx, Kuehne + Nagel International AG, United Parcel Service, CH Robinson. Some of the major domestic players include Eurotranspharma, Centre Spécialités Pharmaceutiques, PostNL Pharma & Care, and Trans-o-Flex Schnell-Lieferdienst GmbH.

Additional Benefits:

The market estimate (ME) sheet in Excel format
3 months of analyst support

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Pharmaceutical Contract Manufacturing Organization (CMO) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

  • $ 4250 - $ 3400 - Get 20% off now!
  • September 2021
  • 211 pages

The global pharmaceutical CMO market was valued at USD 120.29 billion in 2020, and it is expected to reach USD 195.70 billion by 2026, registering a CAGR of 7.85% from 2021 to 2026. COVID-19 pandemic has ...

  • World
  • Europe
  • Pharmaceutical
  • Biopharmaceutical
  • Industry analysis
  • Pharmaceutical Production
  • Health Expenditure


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on